CHL1
Basic information
Region (hg38): 3:196763-409417
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CHL1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 21 | 28 | ||||
missense | 92 | 17 | 114 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 3 | 2 | 6 | ||
non coding | 6 | |||||
Total | 0 | 0 | 92 | 41 | 15 |
Variants in CHL1
This is a list of pathogenic ClinVar variants found in the CHL1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-319781-A-G | Seizure | Uncertain significance (Jan 01, 2019) | ||
3-319783-C-A | not specified | Uncertain significance (Jul 05, 2023) | ||
3-319804-C-G | CHL1-related disorder | Likely benign (Dec 31, 2019) | ||
3-319812-A-G | Likely benign (Jul 10, 2018) | |||
3-319825-C-T | CHL1-related disorder | Benign (Sep 24, 2019) | ||
3-319864-T-G | Benign (Dec 31, 2019) | |||
3-325956-T-A | CHL1-related disorder | Benign (Mar 29, 2018) | ||
3-325962-A-G | not specified | Uncertain significance (Apr 12, 2023) | ||
3-325995-T-C | not specified | Conflicting classifications of pathogenicity (Jun 22, 2021) | ||
3-326022-A-G | CHL1-related disorder | Likely benign (Feb 21, 2023) | ||
3-326061-C-T | not specified | Uncertain significance (Aug 16, 2022) | ||
3-326074-G-C | CHL1-related disorder | Benign (Apr 12, 2022) | ||
3-328173-G-A | Benign (Dec 31, 2019) | |||
3-328192-C-A | not specified | Uncertain significance (Apr 26, 2024) | ||
3-328209-C-T | Likely benign (Feb 09, 2018) | |||
3-328247-G-A | not specified | Likely benign (Dec 21, 2023) | ||
3-328248-G-A | Benign/Likely benign (Jul 01, 2024) | |||
3-328267-A-G | not specified | Uncertain significance (May 05, 2023) | ||
3-328292-G-A | Likely benign (Dec 07, 2019) | |||
3-328292-G-T | Likely benign (Dec 07, 2019) | |||
3-328363-T-G | CHL1-related disorder | Likely benign (Sep 09, 2017) | ||
3-340832-G-A | not specified | Uncertain significance (May 17, 2023) | ||
3-340846-A-C | Likely benign (Dec 31, 2019) | |||
3-340848-A-G | not specified | Uncertain significance (Sep 22, 2023) | ||
3-341925-C-T | Likely benign (Dec 24, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CHL1 | protein_coding | protein_coding | ENST00000256509 | 26 | 212812 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.89e-12 | 1.00 | 125693 | 0 | 55 | 125748 | 0.000219 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.92 | 785 | 647 | 1.21 | 0.0000327 | 8005 |
Missense in Polyphen | 243 | 247.66 | 0.98117 | 3137 | ||
Synonymous | -3.21 | 297 | 234 | 1.27 | 0.0000130 | 2288 |
Loss of Function | 3.83 | 29 | 61.4 | 0.472 | 0.00000270 | 827 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000869 | 0.000866 |
Ashkenazi Jewish | 0.000317 | 0.000298 |
East Asian | 0.0000560 | 0.0000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000178 | 0.000176 |
Middle Eastern | 0.0000560 | 0.0000544 |
South Asian | 0.000166 | 0.000163 |
Other | 0.000330 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Extracellular matrix and cell adhesion protein that plays a role in nervous system development and in synaptic plasticity. Both soluble and membranous forms promote neurite outgrowth of cerebellar and hippocampal neurons and suppress neuronal cell death. Plays a role in neuronal positioning of pyramidal neurons and in regulation of both the number of interneurons and the efficacy of GABAergic synapses. May play a role in regulating cell migration in nerve regeneration and cortical development. Potentiates integrin-dependent cell migration towards extracellular matrix proteins. Recruits ANK3 to the plasma membrane (By similarity). {ECO:0000250}.;
- Pathway
- Splicing factor NOVA regulated synaptic proteins;Developmental Biology;CHL1 interactions;L1CAM interactions;Axon guidance
(Consensus)
Recessive Scores
- pRec
- 0.0966
Intolerance Scores
- loftool
- 0.341
- rvis_EVS
- -0.16
- rvis_percentile_EVS
- 41.92
Haploinsufficiency Scores
- pHI
- 0.392
- hipred
- Y
- hipred_score
- 0.604
- ghis
- 0.502
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.356
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Chl1
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); craniofacial phenotype; taste/olfaction phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- neuron migration;cell adhesion;signal transduction;axon guidance;adult locomotory behavior;exploration behavior;negative regulation of neuron apoptotic process;cognition
- Cellular component
- plasma membrane;integral component of membrane;dendrite;apical part of cell;extracellular exosome
- Molecular function
- protease binding